Bruce Ferguson

An internationally renowned cardiovascular surgeon, Dr. Bruce Ferguson is co-creator of Perfusio’s Multi-Spectral Physiologic Visualization (MSPV) technology and was instrumental in guiding the development of clinical applications and physician adoption of the platform. He was a pioneer in near-infrared fluorescence (NIRF) imaging in cardiac surgery and performed over 1,000 cases using the modality. As an early adopter of data-driven and quality-outcomes medicine with extensive experience.

In clinical databases, Dr. Ferguson is leading Perfusio’s First in Person Certes (FIRST) Study, a multicenter clinical use study of Certes™ across multiple surgical specialties and applications. Dr. Ferguson has been extramurally funded by Health and Human Services entities continuously since 1989 at Washington University in St. Louis, Duke University, Louisiana State University in New Orleans, and the East Carolina University Brody School of Medicine. He is also Principal Investigator on Perfusio’s three STTR and SBIR grant projects to date and led the research required for FDA 510(k) Class II approval of its first form factor, Certes. Dr. Ferguson is a member of the National Academy of Inventors and currently holds 14 patents.